InterHealth buys 7-Keto brand from Humanetics Corporation


Humanetics Corporation, a leading researcher, developer and marketer of pharmaceuticals, medical foods and branded nutraceutical ingredients, announced recently that it has sold its 7-Keto dietary ingredient brand to InterHealth Nutraceuticals, Inc. of Benica, CA (InterHealth). 7-Keto is a clinically tested, patented ingredient that slows the impact of diet and age-related weight gain.

 “Humanetics developed and established the science and value of the 7-Keto brand over the past twenty years,” said Ronald Zenk, President and CEO of Humanetics Corporation. “We have invested heavily in clinical research and believe that 7-Keto is one of the most scientifically sound products on the market.” He added, “We believe InterHealth will continue to strengthen the 7-Keto brand, and that this transaction will allow Humanetics to focus on its strong portfolio of ongoing pharmaceutical development initiatives.”

According to Paul Dijkstra, President and CEO of InterHealth, “7-Keto fits very nicely into InterHealth’s portfolio of science-based, branded, functional ingredients supported by robust clinical trial and safety data. 7-Keto is sold to many of the industry’s most successful finished product brands and holds a strong position in the marketplace.”

Humanetics will retain the rights to continue development of the 7-Keto technology as a promising treatment for post-traumatic stress disorder. A clinical study at the Bay Pines Veteran’s Administration Hospital in Bay Pines Florida is expected to be completed in late 2014.

Read Previous

Sanjay Dave takes responsibility of director (enforcement) at FSSAI

Read Next

FSSAI appoints new members (ex-officio)

Leave a Reply